Sprache: Italienisch
Verlag: Il Pensiero Scientifico Editore, 1979
ISBN 10: 887002038X ISBN 13: 9788870020380
Anbieter: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italien
Brossura. Zustand: new. Roma, 1979; br., pp. 394, ill. Libro.
Anbieter: libreriauniversitaria.it, Occhiobello, RO, Italien
Zustand: NEW.
Zustand: New.
Zustand: As New. Unread book in perfect condition.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 196,33
Anzahl: 1 verfügbar
In den WarenkorbZustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 190,29
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 715 pages. 10.50x8.25x2.00 inches. In Stock.
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, San Diego, 2017
ISBN 10: 0128094001 ISBN 13: 9780128094006
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. Adverse Events and Oncotargeted Kinase Inhibitors Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 215,59
Anzahl: 1 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
EUR 180,07
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
EUR 180,07
Anzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 229,85
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 229,85
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italien
Rilegato. Zustand: new. Milano, 2013; ril., cm 16x24. Libro.
hardcover. Zustand: New. Special order direct from the distributor.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Adverse Events with Biomedicines | Prevention Through Understanding | Giuseppe Tridente | Taschenbuch | xxx | Englisch | 2017 | Springer | EAN 9788847058484 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Erstausgabe
Zustand: New. Num Pages: 672 pages. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 276 x 216. . . 2017. 1st Edition. hardcover. . . . .
Sprache: Englisch
Verlag: Springer Milan, Springer Milan, 2017
ISBN 10: 8847058481 ISBN 13: 9788847058484
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies.
Sprache: Englisch
Verlag: Springer Milan, Springer Milan, 2013
ISBN 10: 8847053129 ISBN 13: 9788847053120
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 285,82
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 715 pages. 10.50x8.25x2.00 inches. In Stock.
Zustand: New. Num Pages: 672 pages. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 276 x 216. . . 2017. 1st Edition. hardcover. . . . . Books ship from the US and Ireland.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 314,74
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 2014 edition. 633 pages. 9.25x6.25x1.50 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 312,58
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. reprint edition. 664 pages. 9.00x6.00x1.25 inches. In Stock.
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, San Diego, 2017
ISBN 10: 0128094001 ISBN 13: 9780128094006
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Hardcover. Zustand: new. Hardcover. Adverse Events and Oncotargeted Kinase Inhibitors Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 392,72
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Like New. Like New. book.
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 633.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 155,63
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 166,29
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 166,29
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Sprache: Englisch
Verlag: Springer Milan, Springer Milan Dez 2013, 2013
ISBN 10: 8847053129 ISBN 13: 9788847053120
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies. 664 pp. Englisch.
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies. 664 pp. Englisch.